These may indicate toxic levels or complications from drug interactions
Benito J, Hongbo L, Wilson WR, Melink TJ, Feliu J, Konoplev S, Estey E, Kantarjian H, Gutheil JC, Andreeff M , Konopleva M
We first validated the buffering phenotype in the follow-up studies, in which SLC25A19 exhibited milder growth fitness defect compared to the control cells in the presence of complex III inhibitor antimycin, complex I inhibitor piericidin and complex V inhibitor oligomycin than in the regular culture condition (Supplementary Fig
The 5-oxoproline is then cleaved by a 5-oxoprolinase to yield glutamate, while Cys-Gly is cleaved by specific cys-gly peptidases to yield cysteine and glycine
Limitations of the study: The sample size is low
Everybody has a different metabolism, liver health, kidney health, gut health, antioxidant levels, and sensitivity to supplements